Literature DB >> 23739109

Dietary treatment of intractable epilepsy.

Mackenzie C Cervenka1, Eric H Kossoff.   

Abstract

PURPOSE OF REVIEW: Dietary therapies for seizure management date back further than pharmacologic interventions, but many neurologists are not familiar with these treatment options. This introduction to dietary therapies will discuss administration of ketogenic diets, comparisons between diet types, evidence-based efficacy of diet therapies in epilepsy treatment, and management of side effects. This review will provide the general neurologist with the skills to identify appropriate candidates for these treatments and to offer comprehensive ongoing care. RECENT
FINDINGS: In adults and children with medically resistant epilepsy, studies have consistently shown a greater than 50% reduction in seizure frequency in approximately one-half of patients within days to months after starting dietary therapy.
SUMMARY: Dietary treatment options for epilepsy include the classic ketogenic diet, the medium-chain triglyceride diet, the modified Atkins diet, and the low glycemic index treatment. These were first used to control seizures in children with intractable epilepsy, but in recent years have also been demonstrated to be safe and effective in children and adults with a broad range of seizure types and are being used with increased frequency worldwide.

Entities:  

Mesh:

Year:  2013        PMID: 23739109     DOI: 10.1212/01.CON.0000431396.23852.56

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  19 in total

1.  Treating refractory generalized epilepsy with stimulation.

Authors:  Lara E Jehi
Journal:  Epilepsy Curr       Date:  2014-03       Impact factor: 7.500

Review 2.  Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy.

Authors:  Satish Agadi; Ashok K Shetty
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

Review 3.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

4.  Management of pediatric status epilepticus.

Authors:  Nicholas S Abend; Tobias Loddenkemper
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

5.  Brain ketones detected by proton magnetic resonance spectroscopy in an infant with Ohtahara syndrome treated with ketogenic diet.

Authors:  Kim M Cecil; Sarah B Mulkey; Xiawei Ou; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2014-06-08

Review 6.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

7.  Ketogenic Diets for Adults With Highly Refractory Epilepsy.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

8.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

Review 9.  Ketogenic Diets for Adult Neurological Disorders.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 10.  Status epilepticus and refractory status epilepticus management.

Authors:  Nicholas S Abend; David Bearden; Ingo Helbig; Jennifer McGuire; Sona Narula; Jessica A Panzer; Alexis Topjian; Dennis J Dlugos
Journal:  Semin Pediatr Neurol       Date:  2014-12-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.